sitagliptin glp 1 agonist Frontiers Mechanism of action for GIP,

What is the status of platelet derived preparations (e.g PRP and PRF)

Its safety during pregnancy or breastfeeding has not been established

Nor was obesity their starting point

Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity

Glucagonlike peptide1 induces cell proliferation and pancreaticduodenum homeobox1 expression and increases endocrine cell mass in the pancreas of old, glucoseintolerant rats

There is ongoing litigation among manufacturers, compounding pharmacies and the FDA on how long compounding pharmacies can dispense the drugs, given that the FDA has announced the resolution of the shortage